Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Salix Pharmaceuticals
Biotech
Bausch Health's Salix loses Mark McKenna—Chutes & Ladders
Bausch Health's Salix loses president McKenna; Bayer nabs dealmaker De Backer from J&J; AltaSciences nabs Charles River exec LeSauteur.
Kyle Blankenship
Sep 6, 2019 9:30am
Salix grabs ex-Asia rights to Mitsubishi Tanabe autoimmune drug
Apr 25, 2019 9:10am
Valeant wins FDA oral Relistor approval and $1B sales potential
Jul 20, 2016 5:06am
